Investor Bracebridge Capital, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Bracebridge Capital, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-21 13D/A MNK / Mallinckrodt PLC 1,093,857 355,449
2024-02-08 13G/A EAC / Edify Acquisition Corp. 500,000 0
2023-11-17 13D/A MNK / Mallinckrodt PLC 2,033,257 1,093,857
2023-08-25 13D/A MNK / Mallinckrodt PLC 2,033,257 2,033,257
2023-06-16 13D MNK / Mallinckrodt PLC 2,033,257 2,033,257
2023-06-15 13G EAC / Edify Acquisition Corp. 500,000 500,000
2023-02-22 13D/A QTNT / Quotient Ltd 81,614
2022-12-15 13D QTNT / Quotient Ltd 125,703
2022-07-06 13G/A CRXT / Clarus Therapeutics Holdings Inc 2,002,495 2,002,495
2022-06-27 13G MNK / Mallinckrodt PLC 2,033,257
2022-02-14 13G/A CRXT / Clarus Therapeutics Holdings Inc 2,229,855 2,002,495
2021-09-17 13G CRXT / Clarus Therapeutics Holdings Inc 2,229,855
2016-05-26 13G/A PTX / Pernix Therapeutics Holdings, Inc. 4,078,735 0
2015-04-27 13G PTX / Pernix Therapeutics Holdings, Inc. 4,078,735